FAU researchers have discovered that tumour cells can hide from antibody therapy in bone marrow
Scientists from the Division of Genetics at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU) in collaboration with Universitätsklinikum Erlangen have made a breakthrough discovery in cancer research.
For the first time, scientists have been able to simulate the complexity of the human immune system and investigate where cancer cells hide when attacked by the immune system. This research is especially relevant for destroying cancer cells through antibody therapy and shows ways that cancer treatment can be improved today. The researchers recently published their findings in the renowned journal Cell Reports.*
Antibodies that are manufactured specifically to fight cancer cells are an essential part of treating breast cancer and lymphoma. They can detect and mark cancer cells in the body so that the malfunctioning cells can be destroyed by the immune system.
However, some cells may survive attacks by the immune system. In the worst case, this can cause tumours to return. 'A key question in cancer therapy is to find out where tumour cells can hide from the immune system,' states Prof. Dr. Falk Nimmerjahn from the Division of Genetics at FAU. 'If we know the answer to this, we can improve current drugs to target where the malformed cells are hiding'.
Two research teams, one from FAU and the other from the Massachusetts Institute of Technology (MIT, Cambridge) (Pallasch et al. Cell), have independently made important breakthroughs in this area. Both research teams were able to show that the effects of antibodies used in human cancer therapy are weakened if tumour cells are found in bone marrow.
'This gives us a unique opportunity to find out how we can improve the antibodies currently used in cancer treatment to remove all tumour cells so that there is actually a chance of curing patients,' says Dr. Anja Lux, research team leader, Division of Genetics, FAU. The significance of these findings is demonstrated by the ability of both research teams to simulate the complexity of the human immune system in their experiments which indicates that the results can be applied to humans with a greater probability.
Further preliminary investigations at MIT lead researchers to believe that a combination of chemotherapy and antibody therapy can lead to greater success in destroying cancer cells in bone marrow. This is an interesting preliminary result which the researchers in Erlangen are intending to take a step further.
'Now that we know where the cancer cells are hiding, we can improve antibody therapy to better activate immune cells in the bone marrow,' explains Prof. Nimmerjahn. This will help to avoid the harmful side effects of chemotherapy, reduce risk for patients and increase chances of curing patients.
*Lux et al., Cell Reports 7, 1-13, 2014; doi:
Pallasch et al., Cell 156, 590-602, 2014
Contact for media:
Prof. Dr. Falk Nimmerjahn
Blandina Mangelkramer | idw - Informationsdienst Wissenschaft
Researchers invent tiny, light-powered wires to modulate brain's electrical signals
21.02.2018 | University of Chicago
The “Holy Grail” of peptide chemistry: Making peptide active agents available orally
21.02.2018 | Technische Universität München
For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.
In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...
Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale
Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...
For photographers and scientists, lenses are lifesavers. They reflect and refract light, making possible the imaging systems that drive discovery through the microscope and preserve history through cameras.
But today's glass-based lenses are bulky and resist miniaturization. Next-generation technologies, such as ultrathin cameras or tiny microscopes, require...
Scientists from the University of Zurich have succeeded for the first time in tracking individual stem cells and their neuronal progeny over months within the intact adult brain. This study sheds light on how new neurons are produced throughout life.
The generation of new nerve cells was once thought to taper off at the end of embryonic development. However, recent research has shown that the adult brain...
Theoretical physicists propose to use negative interference to control heat flow in quantum devices. Study published in Physical Review Letters
Quantum computer parts are sensitive and need to be cooled to very low temperatures. Their tiny size makes them particularly susceptible to a temperature...
15.02.2018 | Event News
13.02.2018 | Event News
12.02.2018 | Event News
21.02.2018 | Life Sciences
21.02.2018 | Life Sciences
21.02.2018 | Materials Sciences